Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
Giménez, Estela; Albert, Eliseo; Zulaica, Joao; Torres, Ignacio; Rusu, Luciana; Moreno, Alicia Rodríguez; Burgos, Javier S; Peiró, Salvador; Salas, Dolores; Vanaclocha, Hermelinda; Limón, Ramón; Alcaraz, María Jesús; Sánchez-Payá, José; Díez-Domingo, Javier; Comas, Iñaki; Gonzáles-Candelas, Fernando; Geller, Ron; Navarro, David.
  • Giménez E; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Albert E; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Zulaica J; Institute for Integrative Systems Biology, Universitat de Valencia-Consejo Superior de Investigaciones Científicas (CSIC), Valencia, Spain.
  • Torres I; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Rusu L; Institute for Integrative Systems Biology, Universitat de Valencia-Consejo Superior de Investigaciones Científicas (CSIC), Valencia, Spain.
  • Moreno AR; Institute for Integrative Systems Biology, Universitat de Valencia-Consejo Superior de Investigaciones Científicas (CSIC), Valencia, Spain.
  • Burgos JS; General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain.
  • Peiró S; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
  • Salas D; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
  • Vanaclocha H; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
  • Limón R; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
  • Alcaraz MJ; General Directorate of Healthcare, Department of Health, Valencian Government, Valencia, Spain.
  • Sánchez-Payá J; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Díez-Domingo J; Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain.
  • Comas I; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Gonzáles-Candelas F; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
  • Geller R; Biomedicine Institute of Valencia, Spanish Research Council (CSIC), Valencia, Spain.
  • Navarro D; Centro Nacional de Investigación Biomédica en Red (CIBER) in Epidemiology and Public Health, SpainJoint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain.
Clin Infect Dis ; 75(1): e865-e868, 2022 Aug 24.
Article in English | MEDLINE | ID: covidwho-1886380
ABSTRACT
A third Comirnaty vaccine dose increased severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain antibody levels (median, 93-fold) and neutralizing antibody titers against Wuhan-Hu-1 (median, 57-fold), Beta (me 22-fold), Delta, (median, 43-fold), and Omicron (median, 8-fold) variants, but had less impact on S-reactive T-cell immunity in nursing home residents.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid